Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/yuhan_corporation_100_financial_n_strategic_swot_analysis_review_en.gif)
Yuhan Corp (000100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Yuhan Corp (Yuhan) discovers, develops, manufactures and markets pharmaceutical products. It offers APIs and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-thrombotic, anti-diabetic, and anti-hyperlipidemics. The company offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. Yuhan provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. The company offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.
Yuhan Corp Key Recent Developments
Mar 24,2021: Yuhan to invest 10 billion won in April Bio, "the second largest shareholder"
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Yuhan Corp (Yuhan) discovers, develops, manufactures and markets pharmaceutical products. It offers APIs and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-thrombotic, anti-diabetic, and anti-hyperlipidemics. The company offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. Yuhan provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. The company offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.
Yuhan Corp Key Recent Developments
Mar 24,2021: Yuhan to invest 10 billion won in April Bio, "the second largest shareholder"
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Yuhan Corp - Key Facts
Yuhan Corp - Key Employees
Yuhan Corp - Major Products and Services
Yuhan Corp - History
Yuhan Corp - Company Statement
Yuhan Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Yuhan Corp - Business Description
Business Segment: Household & Healthcare
Performance
Performance
Business Segment: Lease, Trust & Others
Performance
Business Segment: License Income
Performance
Business Segment: Others
Performance
Business Segment: Overseas
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
R&D Overview
Yuhan Corp - Corporate Strategy
Yuhan Corp - SWOT Analysis
SWOT Analysis - Overview
Yuhan Corp - Strengths
Yuhan Corp - Weaknesses
Yuhan Corp - Opportunities
Yuhan Corp - Threats
Yuhan Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Yuhan Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 24, 2021: Yuhan to invest 10 billion won in April Bio, 'the second largest shareholder'
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Yuhan Corp - Key Facts
Yuhan Corp - Key Employees
Yuhan Corp - Major Products and Services
Yuhan Corp - History
Yuhan Corp - Company Statement
Yuhan Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Company Overview
Yuhan Corp - Business Description
Business Segment: Household & Healthcare
Performance
Performance
Business Segment: Lease, Trust & Others
Performance
Business Segment: License Income
Performance
Business Segment: Others
Performance
Business Segment: Overseas
Overview
Performance
Business Segment: Pharmaceuticals
Overview
Performance
R&D Overview
Yuhan Corp - Corporate Strategy
Yuhan Corp - SWOT Analysis
SWOT Analysis - Overview
Yuhan Corp - Strengths
Yuhan Corp - Weaknesses
Yuhan Corp - Opportunities
Yuhan Corp - Threats
Yuhan Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Yuhan Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 24, 2021: Yuhan to invest 10 billion won in April Bio, 'the second largest shareholder'
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Yuhan Corp, Key Facts
Yuhan Corp, Key Employees
Yuhan Corp, Major Products and Services
Yuhan Corp, History
Yuhan Corp, Other Locations
Yuhan Corp, Subsidiaries
Yuhan Corp, Affiliate
Yuhan Corp, Joint Venture
Yuhan Corp, Key Competitors
Yuhan Corp, Ratios based on current share price
Yuhan Corp, Annual Ratios
Yuhan Corp, Annual Ratios (Cont...1)
Yuhan Corp, Annual Ratios (Cont...2)
Yuhan Corp, Interim Ratios
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Yuhan Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Yuhan Corp, Key Facts
Yuhan Corp, Key Employees
Yuhan Corp, Major Products and Services
Yuhan Corp, History
Yuhan Corp, Other Locations
Yuhan Corp, Subsidiaries
Yuhan Corp, Affiliate
Yuhan Corp, Joint Venture
Yuhan Corp, Key Competitors
Yuhan Corp, Ratios based on current share price
Yuhan Corp, Annual Ratios
Yuhan Corp, Annual Ratios (Cont...1)
Yuhan Corp, Annual Ratios (Cont...2)
Yuhan Corp, Interim Ratios
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Yuhan Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Yuhan Corp, Performance Chart (2016 - 2020)
Yuhan Corp, Ratio Charts
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Yuhan Corp, Performance Chart (2016 - 2020)
Yuhan Corp, Ratio Charts
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021